Respiratory Tract Diseases at Hospital Universitario del Henares
This Pulmonology research program focuses on respiratory tract diseases, with clinical trials centered on idiopathic pulmonary fibrosis and progressive pulmonary fibrosis. The studies are designed to assess whether new treatment approaches can help preserve lung function and improve outcomes for people living with these serious lung conditions.
- Research on idiopathic pulmonary fibrosis aims to better understand treatment effectiveness and support patients with a chronic, scarring lung disease.
- Trials in progressive pulmonary fibrosis are evaluating whether investigational therapies can slow disease progression and improve breathing-related health.
With a small but focused portfolio of 2 clinical trials and 7 investigators, the site is contributing to advances in care for fibrotic lung disease in Coslada, Spain.
Fibrotic Lung Disease Research
Clinical research at this health care institution is concentrated on conditions that cause scarring and gradual loss of lung capacity. The main goal is to evaluate new therapies for their ability to improve or maintain forced vital capacity, an important measure of lung function in patients with fibrotic lung disease.
- Idiopathic pulmonary fibrosis studies are examining whether investigational treatment can improve lung function over time.
- Progressive pulmonary fibrosis trials are assessing treatment benefit in patients whose disease continues to worsen despite standard care.
This research reflects a strong emphasis on testing the efficacy, safety, and tolerability of new options for patients seen at Hospital Universitario del Henares.
